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complications after hip replacement surgery in
non-diabetic patients
Robert G Hahn1,2* and Stefan Ljunggren1,3Abstract
Background: Insulin resistance negatively affects the outcome of surgery in patients with type 2 diabetes. This
association is often believed to be present in other patient populations as well, but studies are lacking on the
influence of preoperative insulin resistance on the clinical course of surgery in non-diabetic patients.
Methods: Sixty non-diabetic patients with a mean age of 68 years underwent a 75-min intravenous glucose
tolerance test (IVGTT) one day before and after elective hip replacement surgery. Patients were regarded to be
either insulin resistant (< median insulin sensitivity) or not (> median insulin sensitivity). Hypotensive events
occurring in the postoperative care unit and complications in the orthopedic ward were recorded. Fatigue and
well-being were assessed via questionnaires.
Results: A total of 52 patients were included in the final analysis. Insulin resistance before surgery was associated
with a lower risk of arterial hypotension in the postoperative care unit (systolic pressure < 80 mmHg; P < 0.05) and
with fewer complications in the orthopedic ward (mean 1.9 versus 1.2 per operation, P < 0.01), particularly with
respect to nausea/vomiting (P < 0.04) and arterial hypotension (P < 0.05). Fewer of these patients had more than
one complication (23% versus 58%, P < 0.001), while no statistical link between preoperative insulin resistance and
fatigue or well-being was evident. Insulin resistance, when measured one day postoperatively, did not correlate with
the number of complications.
Conclusions: Preoperative insulin resistance offers some benefit in the postoperative period and early
convalescence in non-diabetic patients who undergo hip replacement surgery.
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Insulin resistance is an important aspect of glucose me-
tabolism and implies that only a small amount of glu-
cose is cleared from the extracellular fluid in response to
any given insulin secretion [1]. If insulin resistance is
pronounced, as in type 2 diabetes, even a high level of
insulin secretion is insufficient to maintain the plasma
glucose concentration within the normal range.
Insulin resistance may show a ten-fold variation even
in non-diabetic subjects [2], but the clinical significance
of this variation is little appreciated. Diabetes is known* Correspondence: r.hahn@telia.com
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distribution, and reproduction in any mediumto increase the risk of postoperative complications [3],
while the possible influence of insulin resistance on the
surgical outcome in non-diabetic patients has not been
studied.
The present report is an exploratory analysis to deter-
mine whether insulin resistance influences the incidence
of postoperative complications and well-being after elect-
ive hip replacement surgery.
The hypothesis is that insulin resistance increases the
number of complications in non-diabetic patients, just
as it does in those with diabetes. To study this issue, we
compared complications and well-being in non-diabetic
patients depending on their degree of insulin resistance,
as determined by a short Intravenous Glucose Tolerance
Test (IVGTT) [2,4,5].Central Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Hahn and Ljunggren BMC Anesthesiology 2013, 13:39 Page 2 of 7
http://www.biomedcentral.com/1471-2253/13/39Methods
The participants were 60 patients aged between 44 and
89 years (mean, 69 years) who underwent elective total
hip replacement under spinal anesthesia between May
2008 and September 2009. All patients gave their in-
formed consent to participate in the study. Exclusion
criteria included diabetes and other endocrinological
diseases.
The protocol was approved by the Regional Ethics
Committee of Stockholm (Ref. 2007/1628-31/4) as part
of a clinical trial comparing the effects of preoperative
fasting versus the ingestion of water with and without
carbohydrates on postoperative outcomes (ClinicalTrials.
gov NCT01211184). These treatments were found to
have virtually identical outcomes [4], so composite data
are used in the current presentation.
Total hip replacement surgery was performed under
spinal anesthesia with 2.5–4 ml bupivacaine at 5 mg/ml
(AstraZeneca, Södertälje, Sweden). Routine fluid therapy
during the operations consisted of 1,000 ml of acetated
Ringer’s solution and 500 ml of hydroxyethyl starch at
130/0.4 (Voluven, Fresenius Kabi, Bad Homburg,
Germany). However, two patients received no starch,
and four were given 1,000 ml of the starch. Blood loss
was taken as the sum of the visually estimated amounts
present on swabs and dressings and the measured vol-
ume found in suction bottles.
For postoperative pain relief, 22 patients received an
epidural catheter with a continuous infusion of levobu-
pivacaine at 4–7 mg/h and sufentanil at 3–6 μg/h.
Twenty-five patients were given a wound catheter in-
stead, in which 150 mg of ropivacaine and 30 mg of
ketorolac were injected at the end of surgery and during
the first postoperative morning. All patients were also
given oral acetaminophen, and oral oxycodone served as
rescue pain reliever.
Insulin resistance
Insulin resistance was calculated from a 75-min, seven-
sample IVGTT performed in the fasting state on the day
before the surgery and also on the morning of the first
postoperative day. Before the preoperative IVGTT, the
patients had fasted for 4 hours, while before the second,
they had fasted overnight.
The insulin resistance was obtained by dividing the
slope of the mono-exponential elimination curve for glu-
cose by the area under the curve for plasma insulin above
baseline (AUCins) during the IVGTT. This approach re-
cently showed a good correlation with the euglycemic
hyperinsulinemic glucose clamp in volunteers [2,5], as well
as in diabetic and postoperative patients [5].
The mono-exponential elimination curve obtained
from a short IVGTT might be formed by the ratio be-
tween the volume of distribution (Vd) and the clearance(CL) of the injected glucose. Based on a previous study
in volunteers [2], the relationship between the rate of
glucose uptake (Mbw) given by the clamp method and
Vd, CL and AUCins given by the IVGTT after an intra-
venous injection of 0.3 g/kg of glucose can be expressed
by the following regression equation:




The glucose uptake given by the clamp, which is usu-
ally denoted M, was corrected for body weight (Mbw) to
account for the fact that a heavy person is likely to take
up relatively more glucose at maximum insulin stimula-
tion. Moreover, the bolus dose of glucose given as part
of the IVGTT was adjusted for body weight. The reader
should note that a low Mbw implies insulin resistance.
In the previous study in volunteers, the hyperinsuline-
mic glucose clamp yielded values of Mbw ranging from 9
to 62 μmol/min/kg [2] which the equation cited above
could predict from an IVGTT with 25–75th percentiles
of −10% and +16% and a linearity (correlation coeffi-
cient) of 0.80.
An IVGTT of 0.3 g/kg instantly expands the plasma vol-
ume by 10% [6], which might cause cardiovascular strain
in the elderly. Therefore, the dose of glucose was reduced
to 0.2 g/kg, and the intravenous injection time was in-
creased from 1 to 4 min, as suggested previously [6]. The
glucose was administered as a 30% solution, and the
plasma glucose and insulin concentrations were measured
at baseline and at 10, 20, 30, 45, 60, and 75 min.
The plasma glucose concentration was analyzed on
a Modular P (Roche Diagnostics, Tokyo, Japan), and
plasma insulin was analyzed on a Roche-Hitachi Modu-
lar E170 (Hitachi, Tokyo, Japan). CL and Vd were esti-
mated via a Gauss-Newton least-squares regression
routine that was applied to a one-compartment kinetic
model, which had been entered into the computer pro-
gram Matlab 4.2 (Math Works Inc., Natick, MA) as de-
scribed elsewhere [2,4,7].
The IVGTT-derived data on insulin resistance (Mbw)
were dichotomized, and patients were characterized as
being insulin resistant or not, depending on whether
Mbw was below or above the median for the cohort.
Complications
The medical records from the Postoperative Care Unit
(PACU), where the patient spent the first 3–4 hours
after the surgery, were used to let a blinded investigator
count the number of early hypotensive events, which
were defined as a systolic arterial pressure < 80 mmHg.
On the morning of the second postoperative day (48
hours after surgery), a research nurse used a checklist of
18 complications based on the previously published
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et al. [9] to register adverse events occurring in the
orthopedic ward after the patient had left the PACU.
The registered complications summarized the problems
that appeared during the postoperative care period, ex-
cluding the hours spent in the PACU when residual ef-
fects of anesthetic drugs could have affected the clinical
picture.
The listed complications were: need for ventilation or
oxygen, fever (>38°C), pain requiring parenteral rescue
opioid treatment, nausea and vomiting, hypotension (re-
quiring pharmacological therapy or fluid therapy), cardiac
arrhythmias, food intolerance, neurological problems
(confusion, etc.), headache, wound complications, blood
transfusion, kidney problems (oliguria < 500 ml per day or
rise in serum creatinine of >30%), sepsis, pneumonia, pul-
monary edema, myocardial infarction, stroke, and cystitis
(urgency and pain on voiding). Blood transfusion was later
removed from the list because the authors considered it to
be an expected result of the surgery.
Fatigue and well-being
As surgery and insulin resistance may influence well-
being [5,10,11], the patients answered questionnaires
about fatigue and quality of life in the afternoon on the
day before the surgery and then again two weeks after
the operation had been performed.
The degree of fatigue was assessed using the Fatigue
scale Questionnaire (FQ), which consists of 14 questions
covering both the physical and mental aspects of fatigue
[12,13]. A “yes” answer to a question about the presence
of fatigue is graded as a 1, and a “no” answer is graded
as a 2. Uncertain answers are graded as 1.5.Table 1 Demographics and blood chemistry of patients unde
Parameter Insulin resistance* (n = 26)
Age (years) 66 ± 10
Body weight (kg) 90 ± 16
Female / male (N) 15 / 11
Placebo / water / nutrition (N) 10 / 8 / 8
Preoperative blood chemistry
Plasma glucose (mmol/l) 5.0 ± 0.4
Plasma insulin (pmol/l) 61 (33–99)
Insulin sensitivity (μmol/min/kg) 19 (9–24)
Blood hemoglobin (g/L) 137 ± 10
Postoperative blood chemistry**
Plasma glucose (mmol/l) 5.9 ± 1.2
Plasma insulin (pmol/l) 57 (42–73)
Insulin sensitivity (μmol/min/kg) 11 (2–18)
Blood hemoglobin (g/L) 103 ± 16
*Insulin resistance implied that the insulin sensitivity was below the median for the
**Postoperative samples were collected in the morning on the first day after the suThe overall quality of life was assessed via the Health
Index (HI) questionnaire [14,15]. The patient responds
to ten questions about “energy,” temper, mood, fatigue,
loneliness, sleep, vertigo, bowel function, pain, mobility,
and overall health during the past week. Answers can be
given on four levels: 1 = very poor; 2 = rather poor; 3 =
rather good; and 4 = very good. Hence, the highest HI
score is 40, and the lowest is 10.
Statistics
Data showing normal distributions were presented as the
means ± standard deviations. Differences between groups
were evaluated via one-way ANOVA. Data having a
skewed distribution were reported as the median (25th–
75th percentiles), and the differences were studied via the
Mann–Whitney U test. Binary data were evaluated via con-
tingency table analysis, and the relationships between bin-
ary outcomes and other parameters were assessed by
logistic regression analysis. The statistical software was
StatView SE +Graphics for Mac (Abacus Concepts Inc.,
Berkeley, CA, USA) but the logistic regression analysis was
performed by SPSS version 20 (Statistical Package for So-
cial Sciences; IBM, Chicago, 2011). No formal power ana-
lysis was performed because of the post hoc nature of this
report [4]. P < 0.05 was considered statistically significant.
Results
Basic data
Three patients dropped out of the study, and the occa-
sional hemolysis of insulin samples further reduced the
number of evaluable patients to 52.
Before the surgery, the highest plasma glucose concentra-
tion was 6.5 mmol/L (diabetes is defined as >7.0 mmol/L).rgoing elective hip replacement surgery
No insulin resistance (n = 26) Univariate statistics
70 ± 9 NS
75 ± 11 P < 0.001
20 / 6 NS
10 / 7 / 9 NS
5.1 ± 0.7 NS
29 (24–43) P < 0.003
41 (36–46) P < 0.001
130 ± 12 P < 0.05
5.7 ± 1.0 NS
26 (18–50) P < 0.002
21 (13–34) P < 0.003
102 ± 13 NS
cohort.
rgery.
Figure 1 The incidence of arterial hypotension in the
postoperative ward (systolic blood pressure < 80 mmHg).
Low insulin sensitivity implies high insulin resistance. Each point
represents one patient. The dashed lines indicate median values.
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(19–40) μmol/min/kg. Thus, the 26 patients with Mbw of
31 μmol/min/kg and lower were denoted “insulin resistant”
in the following presentation.
Table 1 shows demographic and blood chemistry data
in the presence or absence of insulin resistance.Table 2 Systolic arterial pressure, surgical data, and well-bein
Parameter Insulin resistance (n = 26)
Systolic arterial pressure (mmHg)
Before spinal anesthesia 153 ± 20
After induction 103 ± 24
Mean during surgery 113 ± 24
Mean in postoperative care unit 106 ± 11
Events below 80 mmHg (N) 6
Operating time (min) 104 ± 22
Blood loss (ml) 400 (300–500)
Erythrocyte transfusions (N patients) 4
Postoperative epidural anesthesia (N) 16
Length of hospital stay (days) 5.7 ± 1.4
Fatigue scale (FQ) questionnaire (score)
Before surgery 23.3 ± 3.9
2 weeks after surgery 25.4 ± 2.2
Health index (HI) questionnaire (score)
Before surgery 29 (23–32)
2 weeks after surgery 31 (30–33)
NS = not significant.Hypotension in the PACU
Patients with insulin resistance before surgery were
more prone to develop arterial hypotension in the PACU
(systolic pressure < 80 mmHg; Figure 1, Table 2).
Logistic regression analysis showed that the occur-
rence of hypotension in the PACU correlated independ-
ently with the insulin sensitivity before surgery (P <
0.011) but not with the use of epidural anesthesia, blood
loss, or body weight.
Complications in the orthopedic ward
Patients with insulin resistance before surgery had a
lower incidence of complications in the orthopedic ward,
as recorded during the follow-up 2 days after the surgery
(mean 1.2 versus 1.9 per operation, P < 0.01; Figure 2).
They were also less prone to have more than one com-
plication (23% versus 58%, P < 0.001).
The lower complication rate was primarily due to less
frequent problems with nausea and vomiting (19% versus
46%, P < 0.04) and arterial hypotension (23% versus 50%,
P < 0.05; Table 3).
Logistic regression analysis showed that hypotension
in the orthopedic ward became more common with less
pronounced insulin resistance before the surgery (P <
0.04) and also with increased use of epidural anesthesia
(P < 0.02). In patients with insulin resistance, the risk of
developing late hypotension was 9% (no epidural) and
30% (with epidural), while the corresponding figures for
those without insulin resistance were 31% and 80%,
respectively.g of patients undergoing hip replacement
No insulin resistance (n = 26) Univariate statistics
152 ± 17 NS
98 ± 26 NS
111 ± 11 NS
100 ± 13 NS
14 P < 0.05




6.0 ± 1.3 NS
23.2 ± 3.8 NS
25.1 ± 2.3 NS
29 (26–31) NS
31 (29–35) NS
Figure 2 Insulin sensitivity before (A) and after (B) elective hip
replacement surgery. Low insulin sensitivity = insulin resistance.
A research nurse recorded the number of complications 2 days
postoperatively. The numbers shown on top of the bars in B denote
the number of patients.





















5 12 P < 0.04




















Total 32 50 P < 0.01 *
* Analysis was performed by the Mann–Whitney U test.
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No overall correlation was noted between preoperative in-
sulin resistance and the length of hospital stay. However,
the patients with the most pronounced insulin resistance
(Mbw < 25
th quartile) had longer hospital stays compared
to the others (6.9 days versus 5.6 days; P < 0.01).
The FQ and HI scores before or 2 weeks after surgery
were virtually identical among those with and without
insulin resistance prior to surgery (Table 2).
Postoperative insulin resistance
Those with insulin resistance measured in the first morning
after surgery (< median 18.0 μmol/min/kg) reported greater
improvement in terms of the FQ score 2 weeks postopera-
tively than the other patients did (change +1 vs. +3 points;P < 0.01). This difference was not statistically related to
hypotensive events or erythrocyte transfusions. In contrast,
postoperative insulin resistance did not correlate with the
HI scores.
Discussion
The report finds preoperative insulin resistance to be
relevant to the clinical course of elective hip replace-
ment surgery in non-diabetic patients. Insulin resistance
was associated with a decreased risk of arterial
hypotension developing in the PACU. Insulin resistance
was also followed by a lower number of complications in
the orthopedic ward, to which reductions in nausea,
vomiting, and further hypotensive events primarily con-
tributed. The more stable hemodynamics probably ex-
plains why these patients tended to receive erythrocytes
less often than the others did, although they did not
bleed less. In contrast, insulin resistance before surgery
had limited bearing on the length of hospital stay, and
no statistical relationship was found with pre- or postop-
erative fatigue or quality of life. Hence, the study hy-
pothesis was not only refuted, but the findings, in fact,
were opposite to the assumed ones.
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ance associated with physiological stress and trauma is
poorly understood from a phylogenetic point of view.
The present results are of interest in this context be-
cause they suggest that preoperative insulin resistance
was of some benefit to our patients by improving their
ability to cope with surgery. No negative consequences
could be discerned here, although this scenario will dif-
fer when insulin resistance becomes sufficiently severe
to cause type 2 diabetes.
Interpretation of the results is somewhat complicated
by the fact that insulin resistance usually occurs con-
comitantly with other components of the “metabolic
syndrome.” In the present study, patients with insulin re-
sistance had higher body weights and plasma insulin
levels at baseline than the others did, while the systolic
arterial pressure was virtually identical in the two groups
(Table 1). As expected, insulin resistance was also aggra-
vated by the surgery. At the time when complications
began to arise at the orthopedic ward, the insulin sensi-
tivity was approximately half as high as it had been be-
fore the operations (Table 2), which is in accordance
with previous results obtained via the glucose clamp
method [16]. However, a correlation of insulin resistance
with complications was only apparent when it was mea-
sured prior to the surgery (Figure 2).
Insulin resistance is usually believed to have negative
implications. Any aggravation of the resistance during
surgery should therefore be prevented, if possible, and
this view has hitherto been widely accepted. Control of
trauma-induced insulin resistance can be achieved via
intravenous infusions of glucose and insulin [17,18],
while a more practical prevention is to ingest a carbohy-
drate drink. The ability of one specific drink (Preop,
Nutricia, Wiltshire, UK) to prevent surgery-induced in-
sulin resistance has received some support from two
small studies with high-quality assessments of glucose
metabolism.
The first study comprised 15 patients who underwent
elective hip replacement surgery, but the study group
had markedly greater insulin resistance than the placebo
group did before the surgery [16]. In the present work,
patients with insulin resistance at baseline usually had a
smaller absolute surgery-induced decrease in insulin
sensitivity; the only exception being those with very
many complications (Figure 2).
The second study included 13 abdominal surgery pa-
tients and needed to incorporate the operating time as a
covariate in order to show efficacy [19]. The carbohy-
drate drink significantly reduced nausea and vomiting in
a large group of patients undergoing laparoscopic chole-
cystectomy [10], although these preventive effects have
not been consistent [11,20]. Others have claimed add-
itional soft benefits, such as less thirst while awaitingsurgery. However, none of these studies have evaluated
the effect of preoperative insulin resistance per se on
postoperative complications and well-being.
Limitations include that surgical hemorrhage was
assessed clinically, i.e. as the summary of the measured
volume in suction bottles and visually estimated amounts
present on swabs and dressings. With this approach blood
loss did not differ depending on the degree insulin re-
sistance, but it is possible that a difference had been
disclosed if the lost blood had been had washed out
from the swabs by saline and the amount measured by a
photometer.
The choice of cutoff point for arterial hypotension can
be debated. During the induction of anesthesia, an acute
reduction of the systolic pressure by 25–30% or more
is often regarded as representing hypotension [21]. How-
ever, our criterion is justified by the fact that the postoper-
ative hypotension was subacute [22]; most of the total
decrease in arterial pressure had already occurred during
anesthesia and surgery (Table 2). Moreover, systolic pres-
sures below 80 mmHg attenuate the autoregulation of the
renal blood flow and the glomerular filtration rate, and are
frequently accompanied by near-fainting.
Another limitation is that insulin sensitivity was mea-
sured via IVGTT and not via the glucose clamp, al-
though the former is claimed to be a fully acceptable
alternative [1]. The clamp was considered unsuitable for
this study because it induces an extreme physiological
situation for 3–4 hours, which could have modified the
incidence of surgical complications. One should also be
aware that the results are based on exploratory analyses
from a clinical trial [4]. Although the clinical implication
here is that efforts to reduce insulin resistance prior to
surgery are hardly worthwhile, this view needs to be
challenged in a prospective study.Conclusion
Preoperative insulin resistance in non-diabetic patients
was associated with a lower incidence of complications
after elective hip replacement surgery performed under
spinal anesthesia.
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